How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?

Area of Science:

• Cellular Biology
• Molecular Biology
• Biochemistry

Background:

• Multiple cell death mechanisms, including apoptosis, necroptosis, and pyroptosis, are tightly regulated by protein interactions.
• The interleukin-1 receptor antagonist (IL-1Ra) typically inhibits IL-1α/β inflammatory effects by binding to the IL-1 receptor.

Purpose of the Study:

• To elucidate a novel role for IL-1Ra in the regulation of cell death pathways.
• To understand the molecular mechanism by which IL-1Ra influences apoptosis and necroptosis.

Main Methods:

• Coimmunoprecipitation assays
• Enzyme activity assays
• Molecular dynamics simulations (10 μs cumulative)
• Consensus docking

Main Results:

• IL-1Ra noncompetitively inhibits caspase-8 and caspase-9 activity in advanced pathological states.
• IL-1Ra binds to the dimeric interface of caspase-8 and -9, preventing active form generation.
• IL-1Ra/caspase adducts are stabilized by hydrophobic and hydrogen bonding interactions, similar to known caspase inhibitors XIAP and c-FLIP.

Conclusions:

• IL-1Ra acts as a novel regulator in the cell death network, beyond its known anti-inflammatory function.
• Atomic-level understanding of IL-1Ra's interaction with caspases provides insights into therapeutic interventions.
• Targeting IL-1Ra's novel mechanism may offer new strategies for treating diseases involving dysregulated cell death.